Disease management

A person standing on the Cardiac Scale.
Bodyport receives FDA 510(k) for connected scale
By Emily Olsen | 02:12 pm | August 09, 2022
The Cardiac Scale monitors patients with fluid management conditions like heart failure and kidney disease.
A woman using her smartphone.
Digital gastrointestinal care startup Salvo Health launches with $10.5M
By Emily Olsen | 11:56 am | August 08, 2022
The company offers a virtual clinic for people with chronic gut conditions like irritable bowel syndrome and gastroesophageal reflux disease.
VUNO Hativ Pro personal ECG device
South Korea clears VUNO's personal ECG device
By Adam Ang | 03:00 am | August 04, 2022
The clearance signals the company's move to offer medical AI devices to consumers.
A medical professional and a patient talking to another provider using a tablet.
Caption Health partners with Heartbeat Health for remote cardiac care
By Emily Olsen | 01:12 pm | July 29, 2022
Clinicians will use Caption's AI-enabled guidance software to perform ultrasounds, even in patients' homes. Heartbeat's virtual cardiologists will receive and interpret the results remotely.
Adherium's Hailie solution featuring sensor and mobile and desktop applications
Adherium gets US FDA 510(k) to connect remote monitoring sensor for Ellipta inhaler users
By Adam Ang | 01:14 am | July 28, 2022
It follows the clearance for connecting Hailie with AstraZeneca's Symbicort inhaler.
A doctor holding a tablet while talking to a patient.
Direct primary care provider Everside Health scores $164M
By Emily Olsen | 01:47 pm | July 25, 2022
Everside recently scrapped plans for an IPO due to market conditions.
A doctor and a patient looking at information on a tablet.
iRhythm Technologies receives another FDA 510(k) for AFib monitoring system
By Emily Olsen | 01:08 pm | July 22, 2022
The latest clearance is for an algorithm that characterizes how much atrial fibrillation a patient is experiencing over time.
A doctor helping a patient set up a wearable watch
Study: Wearables can empower patients, but barriers prevent greater adoption
By Emily Olsen | 01:21 pm | July 14, 2022
Researchers found three themes in their review of studies on wearables: the role of providers and potential benefits to care, driving behavior change and barriers to use.
[Left] Ed Deng, co-founder and CEO, Health2Sync; and [Right] Claudio Longo, President, AstraZeneca Taiwan
Health2Sync, AstraZeneca to roll out digital support tool for early CKD detection in Taiwan
By Adam Ang | 12:01 am | July 13, 2022
Health2Sync has upgraded its patient management platform to identify patients' CKD risk levels.
The Minuteful test kit, including a smartphone displaying the app
Healthy.io receives FDA clearance for smartphone-based home kidney test
By Emily Olsen | 10:41 am | July 12, 2022
This marks the urinalysis and wound-care company's third 510(k) clearance.